Towards the optimal antihistamine: studies with ebastine.
Roberts
D J
DJ
Almirall Prodesfarma S.A., Barcelona, Spain. droberts@almirall.prodesfarma.com
D000818:Animals; D016084:Bronchoconstriction / Q000187:drug effects; D002090:Butyrophenones / Q000737:chemistry / Q000494:pharmacology* / Q000633:toxicity; D006168:Guinea Pigs; D006331:Heart Diseases / Q000139:chemically induced; D006634:Histamine H1 Antagonists / Q000494:pharmacology* / Q000633:toxicity; D010880:Piperidines / Q000737:chemistry / Q000494:pharmacology* / Q000633:toxicity; D015221:Potassium Channels / Q000187:drug effects; D051381:Rats; D013329:Structure-Activity Relationship; D016593:Terfenadine / Q000737:chemistry / Q000494:pharmacology / Q000633:toxicity
D002090:Butyrophenones; D006634:Histamine H1 Antagonists; D010880:Piperidines; D015221:Potassium Channels; C058251:carebastine; D016593:Terfenadine; C058249:ebastine